Endpoints News 14. Mai 2026 BeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclexta
Endpoints News 13. Mai 2026 After an apparent cure, a gene editing company struggles to repeat the magic
Endpoints News 13. Mai 2026 Merck KGaA's clients are stockpiling due to Iran war, supporting guidance boost
Endpoints News 12. Mai 2026 Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance options